Bristol-Myers Squibb Company
BMY
$47.85
$1.302.79%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.05B | 5.42B | -8.95B | -7.26B | -6.54B |
| Total Depreciation and Amortization | 6.48B | 8.09B | 9.58B | 10.18B | 10.02B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.25B | 2.06B | 13.75B | 11.70B | 11.72B |
| Change in Net Operating Assets | 1.13B | -1.26B | 810.00M | 389.00M | -1.03B |
| Cash from Operations | 15.90B | 14.31B | 15.19B | 15.00B | 14.16B |
| Capital Expenditure | -1.32B | -1.22B | -1.25B | -1.20B | -1.22B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -758.00M | -1.85B | -21.82B | -22.36B | -22.33B |
| Divestitures | 1.10B | 1.10B | 1.10B | 1.01B | 999.00M |
| Other Investing Activities | -407.00M | -264.00M | 618.00M | 46.00M | -141.00M |
| Cash from Investing | -1.39B | -2.23B | -21.35B | -22.50B | -22.69B |
| Total Debt Issued | 116.00M | 384.00M | 15.97B | 20.60B | 20.49B |
| Total Debt Repaid | -3.39B | -5.87B | -5.87B | -7.99B | -5.25B |
| Issuance of Common Stock | -- | -- | -- | 25.00M | 27.00M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -4.00B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.95B | -4.91B | -4.86B | -4.81B | -4.78B |
| Other Financing Activities | -95.00M | -112.00M | -106.00M | -87.00M | -64.00M |
| Cash from Financing | -8.32B | -10.51B | 5.13B | 7.74B | 6.43B |
| Foreign Exchange rate Adjustments | 124.00M | -26.00M | -137.00M | 88.00M | -27.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.32B | 1.54B | -1.17B | 325.00M | -2.13B |